Discover management strategies for alopecia areata, from anti-inflammatory diets to stress reduction techniques that can help ...

Medically reviewed by Susan Bard, MD Alopecia areata is a common hair loss condition. It affects people of all ages, races, ...

While similarities exist between types of alopecia, distinct clinical characteristics help patients & physicians ...

Elizabeth Sevigny reached rock bottom when her hair started to fall out, but everything changed when she had a baby and entered the world of pageantry.

The Food and Drug Administration has granted Fast Track designation to bempikibart for the treatment of alopecia areata.

Alopecia areata, the autoimmune condition Theroux been dealing with since 2022, causes unpredictable hair loss. Over the past couple of years, he’s shared candid updates about his journey, including ...

Significant unmet needs were found among high-quality validation studies on the internal structure of patient-reported ...

Eli Lilly and Incyte's Olumiant has secured the first FDA approval for a systemic drug to treat alopecia areata, an autoimmune condition causing patchy hair loss that affects more than 700,000 ...

When it comes to the world of hair loss, it’s no question that the amount of information out there can feel extremely ...

Alopecia areata causes patches of baldness about the size of a large coin - with both men and women equally affected. Kaz - donning her stylish cropped hairstyle - was back on-screen for the All ...

Bempikibart (ADX-914) is a human anti-IL-7Rα antibody that blocks the IL-7 and TSLP pathways, which have been implicated in driving T cell-mediated pathological processes in autoimmune diseases.